Two faces of nitric oxide: lessons learned from the NOS2 knockout.
Hoit
B D
BD
D000818:Animals; D017209:Apoptosis / Q000187:drug effects / Q000502:physiology; D002147:Calmodulin / Q000378:metabolism; D002451:Cell Compartmentation / Q000502:physiology; D002470:Cell Survival / Q000187:drug effects / Q000502:physiology; D004285:Dogs; D006321:Heart / Q000187:drug effects / Q000502:physiology; D051379:Mice; D018345:Mice, Knockout; D009200:Myocardial Contraction / Q000187:drug effects / Q000502:physiology; D009206:Myocardium / Q000201:enzymology; D009569:Nitric Oxide / Q000378:metabolism* / Q000494:pharmacology; D019001:Nitric Oxide Synthase / Q000172:deficiency* / Q000235:genetics / Q000378:metabolism*; D052248:Nitric Oxide Synthase Type I; D052247:Nitric Oxide Synthase Type II; D052250:Nitric Oxide Synthase Type III; D010084:Oxidation-Reduction; D014666:Vasomotor System / Q000187:drug effects / Q000502:physiology; D016277:Ventricular Function, Left / Q000187:drug effects; D020257:Ventricular Remodeling / Q000502:physiology
D002147:Calmodulin; D009569:Nitric Oxide; D019001:Nitric Oxide Synthase; D052248:Nitric Oxide Synthase Type I; D052247:Nitric Oxide Synthase Type II; D052250:Nitric Oxide Synthase Type III; C496321:Nos1 protein, mouse; C496317:Nos2 protein, mouse; C496315:Nos3 protein, mouse